Related content

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol–cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

By Elter Koray   Imir Gonca   Durmusoglu Fatih  

Human Reproduction, Vol. 17, Iss. 7, 2002-07 ,pp. : 1729-1737

Oxford University Press

Access to resources Recommend Favorite

Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin

By Luque-Ramrez Manuel   lvarez-Blasco Francisco   Uriol Rivera Miguel Giovanni   Escobar-Morreale Hctor F.  

Human Reproduction, Vol. 23, Iss. 7, 2008-07 ,pp. : 1594-1601

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome

By Arikan Şenay   Bahceci Mithat   Tuzcu Alpaslan   Kale Ebru   Gökalp Deniz  

Gynecological Endocrinology, Vol. 26, Iss. 3, 2010-03 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite